Michio Noda
Papers
2
Total Citations
8
H-Index
2
About
Dr. Michio Noda is a pioneering urologic oncologist whose research focuses on the surgical and radiotherapeutic management of genitourinary malignancies, particularly prostate and renal cancers. His most impactful work directly compares long-term outcomes of modern treatment modalities. In a landmark 2024 propensity score-matched analysis, Dr. Noda demonstrated that robot-assisted radical prostatectomy (RARP) offers comparable six-year survival outcomes to volumetric modulated arc therapy (VMAT) for localized prostate cancer, providing critical data to guide shared decision-making. This study, along with his earlier work, has garnered significant attention in the field. Dr. Noda also made a notable contribution to the understanding of rare synchronous pathologies, reporting the first case of intravascular large B-cell lymphoma incidentally discovered within a renal cell carcinoma specimen during robot-assisted partial nephrectomy. This 2022 case report, with 5 citations, highlights his meticulous surgical approach and diagnostic acumen. With a cumulative citation count exceeding 8, Dr. Noda’s research is shaping clinical practice by clarifying the comparative effectiveness of robotic surgery and advanced radiotherapy, ultimately improving outcomes for patients with urologic cancers.
Research Focus
Key Achievements
Top Papers
- 1
- 2